Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT02865005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Multi-center, double-blind, randomized, placebo-controlled trial of Dapsone 5.0% Gel in the treatment of acne vulgaris.
Study identification
- NCT ID
- NCT02865005
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,361 participants
Conditions and interventions
Conditions
Interventions
- Dapsone 5.0% Gel (SEEGPharm) Drug
- Placebo Other
- Dapsone 5.0% Gel (Allergan) Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2016 (Type not available)
- Primary completion
- Nov 2016 (Actual)
- Completion
- Dec 2016 (Actual)
- Last update posted
- Dec 20, 2016
2016
United States locations
- U.S. sites
- 35
- U.S. states
- 14
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Catawba Clinical Research | Encino | California | 91436 | — |
| Catawba Clinical Research | Fullerton | California | 92835 | — |
| Catawba Clinical Research | La Mesa | California | 91942 | — |
| Catawba Clinical Research | Los Angeles | California | 90017 | — |
| Catawba Clinical Research | Los Angeles | California | 90036 | — |
| Catawba Clinical Research | Sherman Oaks | California | 91403 | — |
| Catawba Clinical Research | Temecula | California | 92592 | — |
| Catawba Clinical Research | Boca Raton | Florida | 33486 | — |
| Catawba Clinical Research | Brandon | Florida | 33511 | — |
| Catawba Clinical Research | Hialeah | Florida | 33016 | — |
| Catawba Clinical Research | Miami | Florida | 33175 | — |
| Catawba Clinical Research | Miramar | Florida | 33027 | — |
| Catawba Clinical Research | South Tampa | Florida | 33609 | — |
| Catawba Clinical Research | Tampa | Florida | 33618 | — |
| Catawba Clinical Research | Savannah | Georgia | 31406 | — |
| Catawba Clinical Research | New Orleans | Louisiana | 70130 | — |
| Catawba Clinical Research | Norfolk | Nebraska | 68701 | — |
| Catawba Clinical Research | Omaha | Nebraska | 68134 | — |
| Catawba Clinical Research | Las Vegas | Nevada | 89106 | — |
| Catawba Clinical Research | Las Vegas | Nevada | 89109 | — |
| Catawba Clinical Research | Las Vegas | Nevada | 89119 | — |
| Catawba Clinical Research | Endwell | New York | 13760 | — |
| Catawba Clinical Research | New York | New York | 10012 | — |
| Catawba Clinical Research | High Point | North Carolina | 27262 | — |
| Catawba Clinical Research | Wilmington | North Carolina | 28405 | — |
| Catawba Clinical Research | Cincinnati | Ohio | 45246 | — |
| Catawba Clinical Research | Jenkintown | Pennsylvania | 19046 | — |
| Catawba Clinical Research | Upper Saint Clair | Pennsylvania | 15241 | — |
| Catawba Clinical Research | Warminster | Pennsylvania | 18974 | — |
| Catawba Clinical Research | Nashville | Tennessee | 37215 | — |
| Catawba Clinical Research | Austin | Texas | 78746 | — |
| Catawba Clinical Research | El Paso | Texas | 79902 | — |
| Catawba Clinical Research | Mesquite | Texas | 75149 | — |
| Catawba Clinical Research | Norfolk | Virginia | 23507 | — |
| Catawba Clinical Research | Richland | Washington | 97030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02865005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2016 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02865005 live on ClinicalTrials.gov.